Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Togashi

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Diabetes|June 27, 2013
Glucokinase activation ameliorates ER stress-induced apoptosis in pancreatic β-cellsJun Shirakawa, Yu Togashi, Eri Sakamoto, et al.
Diabetes Research and Clinical Practice|April 14, 2012
Plasminogen activator inhibitor-1 is associated with renal dysfunction independent of BMI and serum lipid levels in patients with type 2 diabetesJun Shirakawa, Yu Togashi, Kazuki Tajima, et al.
Endocrine Journal|January 21, 2010
Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA1cKaori Kikuchi, Uru Nezu, Jun Shirakawa, et al.
The Journal of Biological Chemistry|May 27, 2011
Protective effects of dipeptidyl peptidase-4 (DPP-4) inhibitor against increased β cell apoptosis induced by dietary sucrose and linoleic acid in mice with diabetesJun Shirakawa, Kikuko Amo, Hirokazu Ohminami, et al.
Diabetology & Metabolic Syndrome|March 4, 2016
DPP-4 inhibition improves early mortality, β cell function, and adipose tissue inflammation in db/db mice fed a diet containing sucrose and linoleic acidJun Shirakawa, Tomoko Okuyama, Mayu Kyohara, et al.
Internal Medicine (Tokyo, Japan)|May 17, 2021
Effects of Canagliflozin on Hepatic Steatosis, Visceral Fat and Skeletal Muscle among Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver DiseaseNoriko Nishimiya, Kazuki Tajima, Kento Imajo, et al.
Endocrinology|April 10, 2014
Effects of the antitumor drug OSI-906, a dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, β-cell functions, and β-cell proliferation in male miceJun Shirakawa, Tomoko Okuyama, Eiko Yoshida, et al.
Diabetes Research and Clinical Practice|December 26, 2008
Comparison of pre- versus post-meal administration of voglibose in men with or without impaired glucose toleranceKazutaka Aoki, Yuzuru Ito, Kaori Saito, et al.
Endocrinology|November 28, 2012
Trefoil factor 2 promotes cell proliferation in pancreatic β-cells through CXCR-4-mediated ERK1/2 phosphorylationKazuki Orime, Jun Shirakawa, Yu Togashi, et al.
Endocrinology|February 13, 2014
β-Cell proliferation after a partial pancreatectomy is independent of IRS-2 in miceYu Togashi, Jun Shirakawa, Kazuki Orime, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Diabetes|June 27, 2013
Glucokinase activation ameliorates ER stress-induced apoptosis in pancreatic β-cellsJun Shirakawa, Yu Togashi, Eri Sakamoto, et al.
Diabetes Research and Clinical Practice|April 14, 2012
Plasminogen activator inhibitor-1 is associated with renal dysfunction independent of BMI and serum lipid levels in patients with type 2 diabetesJun Shirakawa, Yu Togashi, Kazuki Tajima, et al.
Endocrine Journal|January 21, 2010
Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA1cKaori Kikuchi, Uru Nezu, Jun Shirakawa, et al.
The Journal of Biological Chemistry|May 27, 2011
Protective effects of dipeptidyl peptidase-4 (DPP-4) inhibitor against increased β cell apoptosis induced by dietary sucrose and linoleic acid in mice with diabetesJun Shirakawa, Kikuko Amo, Hirokazu Ohminami, et al.
Diabetology & Metabolic Syndrome|March 4, 2016
DPP-4 inhibition improves early mortality, β cell function, and adipose tissue inflammation in db/db mice fed a diet containing sucrose and linoleic acidJun Shirakawa, Tomoko Okuyama, Mayu Kyohara, et al.
Internal Medicine (Tokyo, Japan)|May 17, 2021
Effects of Canagliflozin on Hepatic Steatosis, Visceral Fat and Skeletal Muscle among Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver DiseaseNoriko Nishimiya, Kazuki Tajima, Kento Imajo, et al.
Endocrinology|April 10, 2014
Effects of the antitumor drug OSI-906, a dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, β-cell functions, and β-cell proliferation in male miceJun Shirakawa, Tomoko Okuyama, Eiko Yoshida, et al.
Diabetes Research and Clinical Practice|December 26, 2008
Comparison of pre- versus post-meal administration of voglibose in men with or without impaired glucose toleranceKazutaka Aoki, Yuzuru Ito, Kaori Saito, et al.
Endocrinology|November 28, 2012
Trefoil factor 2 promotes cell proliferation in pancreatic β-cells through CXCR-4-mediated ERK1/2 phosphorylationKazuki Orime, Jun Shirakawa, Yu Togashi, et al.
Endocrinology|February 13, 2014
β-Cell proliferation after a partial pancreatectomy is independent of IRS-2 in miceYu Togashi, Jun Shirakawa, Kazuki Orime, et al.
Pageof 5